Zentalis Pharmaceuticals Llc
Biotechnology
Healthcare
ZNTL
71.68 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.52
52 week high
4.57
high
1.54
52 week low
0.00
low
1.46
growth
-64.45 %
previous Close
1.52
P/E ratio
market cap
96.42 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top